CTIS.eu › Cities › Netherlands › Amsterdam
Amsterdam
Netherlands
1,112 total trials
514 recruiting
Filter these 1,112 trials by phase, condition, sponsor and more.
Open in Search →
2024-513509-30-00
5
2016-01-11
Progressive or recurrent germ cell tumor (measurable or non-measurable
2024-511380-29-00
3
2015-12-16
Newly Diagnosed Acute Myeloid Leukemia with an IDH1 and/or IDH2 Mutati
2024-513454-29-00
5
2015-10-15
Non-Small Cell Lung Cancer (NSCLC)
2025-520487-18-00
4
2015-09-08
Triple negative breast cancer (TNBC) patients with metastatic disease
2024-513521-23-00
5
2015-08-19
Prostate Cancer
2023-509136-25-00
5
2015-07-16
Stage III melanoma (AJCC R0) with histologically confirmed cutaneous m
2023-508606-26-00
5
2015-04-23
Metastatic castration-resistant prostate cancer (mCRPC)
2022-502324-48-00
5
2014-08-05
Patients with resected colon carcinoma
2024-511096-15-00
5
2014-08-01
Breast Cancer
2023-503423-25-00
5
2014-06-19
Burkitt lymphoma
2024-516202-39-00
4
2013-10-10
Metastatic breast cancer
2024-511142-39-00
5
2013-09-06
BRCA Mutated Advanced (FIGO Stage III-IV) Ovarian Cancer
2023-506194-35-00
5
2024-11-21
Colorectal liver metastases
2023-505858-18-00
1
2024-06-28
Pancreatic carcinoma
2023-503298-39-00
5
2024-06-13
Metastatic Non-Small Cell Lung Cancer (mNSCLC)
2022-502137-26-00
1
2024-05-03
B-cell Non-Hodgkins Lymphoma (B-NHL)
2024-514588-24-00
7
2021-09-27
Acute Myeloid Leukaemia (AML)
2024-511227-33-00
3
Metastatic colorectal cancer
2025-521325-33-00
4
2026-03-18
Chronic angina and left ventricular dysfunction due to coronary artery
2024-518461-10-00
5
2026-01-12
WHIM Syndrome
2024-519856-94-00
4
2025-08-18
Cystic fibrosis
2024-513440-29-00
10
2025-06-25
Sickle cell disease vaso-occlusive crisis
2024-514745-10-00
1
2025-06-23
Melanoma (or) malignant melanoma
Non-small cell lung cancer
Head and n
2024-516699-14-00
7
2025-04-23
Non Small Cell Lung Cancer
Colorectal Cancer
Pancreatic Ductal Adenoca
Showing 889–912 of 1,112 trials